Trupanion, Inc. (NASDAQ:TRUP – Get Free Report)’s stock price was down 10.1% on Friday after Canaccord Genuity Group lowered their price target on the stock from $40.00 to $34.00. Canaccord Genuity Group currently has a buy rating on the stock. Trupanion traded as low as $21.32 and last traded at $21.38. Approximately 502,239 shares changed hands during trading, a decline of 24% from the average daily volume of 659,466 shares. The stock had previously closed at $23.78.
TRUP has been the subject of a number of other research reports. Stifel Nicolaus lifted their target price on shares of Trupanion from $25.00 to $28.00 and gave the company a “hold” rating in a research note on Friday, February 16th. Evercore ISI dropped their target price on Trupanion from $35.00 to $31.00 and set an “outperform” rating on the stock in a research report on Tuesday, February 20th. Finally, Piper Sandler lowered their price target on Trupanion from $28.00 to $22.00 and set a “neutral” rating for the company in a research note on Friday. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $32.33.
Read Our Latest Analysis on TRUP
Institutional Trading of Trupanion
Trupanion Trading Down 16.5 %
The company has a debt-to-equity ratio of 0.42, a current ratio of 1.63 and a quick ratio of 1.63. The company has a market capitalization of $833.60 million, a price-to-earnings ratio of -18.38 and a beta of 1.76. The business has a fifty day moving average price of $25.67 and a 200 day moving average price of $26.77.
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its quarterly earnings data on Thursday, May 2nd. The financial services provider reported ($0.16) EPS for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.02. Trupanion had a negative net margin of 4.03% and a negative return on equity of 15.19%. The business had revenue of $306.12 million during the quarter, compared to analyst estimates of $300.51 million. During the same quarter in the prior year, the business earned ($0.60) earnings per share. The firm’s revenue for the quarter was up 19.4% on a year-over-year basis. On average, equities analysts expect that Trupanion, Inc. will post -0.43 EPS for the current fiscal year.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
See Also
- Five stocks we like better than Trupanion
- What is the Australian Securities Exchange (ASX)
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- The How And Why of Investing in Oil Stocks
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.